Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Journal for ImmunoTherapy of Cancer

Fig. 5

From: Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia

Fig. 5

NKG2DL expression on primary AML samples. NKG2DL surface expression on primary AML cells of the patient samples employed in our study (n = 18) was analyzed by flow cytometry using a NKG2D-Fc chimera or isotype control (1 μg/mL) as described in the methods section. a SFI levels of NKG2DL expression of individual patients (threshold for surface positivity was defined as SFI ≥ 1.5 (dashed line), mean of the SFI levels (solid line)) are shown. b Percentage of NKG2DL+ AML cells within each sample is shown. Mean of percentage is depicted as solid line

Back to article page